Meta-analysis of cell therapy trials for patients with heart failure

Circulation Research

Volumn 116, Issue 8, 2015, Pages 1361-1377

  Fisher, Sheila A ^a,b   Doree, Carolyn ^a,b   Mathur, Anthony ^c   Martin Rendon, Enca ^a,b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cell therapy; Heart failure; Meta analysis; Randomized controlled trials; Stem cells

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADVERSE OUTCOME; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIOVASCULAR MORTALITY; CELL THERAPY; ENDOTHELIAL PROGENITOR CELL; EXERCISE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HOSPITAL READMISSION; HUMAN; INCIDENCE; MESENCHYMAL STEM CELL; META ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; AUTOTRANSPLANTATION; CHI SQUARE DISTRIBUTION; CONVALESCENCE; DISEASE FREE SURVIVAL; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATION; RISK; RISK FACTOR; TIME;

CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; HEART FAILURE; HUMANS; MYOCARDIAL CONTRACTION; ODDS RATIO; PATIENT READMISSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; REGENERATION; RISK FACTORS; STEM CELL TRANSPLANTATION; STROKE VOLUME; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84930787836     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304386     Document Type: Article

References (70)

1. McMurray JJ, Adamopoulos S, Anker SD, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869. doi: 10.1093/eurjhf/hfs105
2. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad
3. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014 129 e28 e292. doi: 10.1161/01.cir.0000441139.02102.80
4. Heidenreich PA, Trogdon JG, Khavjou OA, American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123: 933-944. doi: 10.1161/CIR.0b013e31820a55f5
5. Taggart DP, Incomplete revascularization: appropriate and inappropriate. Eur J Cardiothorac Surg 2012; 41: 542-543. doi: 10.1093/ejcts/ezr298
6. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, International Society of Heart and Lung Transplantation The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012. J Heart Lung Transplant 2012; 31: 1052-1064. doi: 10.1016/j.healun.2012.08.002
7. Kirklin JK, Naftel DC, Kormos RL, Pagani FD, Myers SL, Stevenson LW, Givertz MM, Young JB, Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant. J Heart Lung Transplant 2013; 32: 1205-1213. doi: 10.1016/j.healun.2013.09.001
8. Leistner DM, Fischer-Rasokat U, Honold J, Seeger FH, Schächinger V, Lehmann R, Martin H, Burck I, Urbich C, Dimmeler S, Zeiher AM, Assmus B, Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol 2011; 100: 925-934. doi: 10.1007/s00392-011-0327-y
9. Heldman AW, DiFede DL, Fishman JE, Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 2014; 311: 62-73. doi: 10.1001/jama.2013.282909
10. Vrtovec B, Poglajen G, Sever M, Lezaic L, Domanovic D, Cernelc P, Haddad F, Torre-Amione G, Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail 2011; 17: 272-281. doi: 10.1016/j.cardfail.2010.11.007
11. Perin EC, Willerson JT, Pepine CJ, Cardiovascular Cell Therapy Research Network (CCTRN) Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 2012; 307: 1717-1726. doi: 10.1001/jama.2012.418
12. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B, Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012; 126: 551-568. doi: 10.1161/CIRCULATIONAHA.111.086074
13. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E, Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012 2 CD006536. doi: 10.1002/14651858.CD006536.pub3
14. Wen Y, Meng L, Xie J, Ouyang J, Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis. Expert Opin Biol Ther 2011; 11: 559-567. doi: 10.1517/14712598.2011.560567
15. Kandala J, Upadhyay GA, Pokushalov E, Wu S, Drachman DE, Singh JP, Meta-analysis of stem cell therapy in chronic ischemic cardiomyopathy. Am J Cardiol 2013; 112: 217-225. doi: 10.1016/j.amjcard.2013.03.021
16. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E, Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev 2014 4 CD007888. doi: 10.1002/14651858.CD007888.pub2
17. Tian T, Chen B, Xiao Y, Yang K, Zhou X, Intramyocardial autologous bone marrow cell transplantation for ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials. Atherosclerosis 2014; 233: 485-492. doi: 10.1016/j.atherosclerosis.2014.01.027
18. Cheng K, Wu F, Cao F, Intramyocardial autologous cell engraftment in patients with ischaemic heart failure: a meta-analysis of randomised controlled trials. Heart Lung Circ 2013; 22: 887-894. doi: 10.1016/j.hlc.2013.04.112
19. Pokushalov E, Romanov A, Chernyavsky A, Larionov P, Terekhov I, Artyomenko S, Poveshenko O, Kliver E, Shirokova N, Karaskov A, Dib N, Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 2010; 3: 160-168. doi: 10.1007/s12265-009-9123-8
20. Bartunek J, Behfar A, Dolatabadi D, Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 2013; 61: 2329-2338. doi: 10.1016/j.jacc.2013.02.071
21. Perin EC, Sanz-Ruiz R, Sanchez PL, Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE trial. Am Heart J 2014; 168: 88-95. e82
22. Assmus B, Walter DH, Seeger FH, Leistner DM, Steiner J, Ziegler I, Lutz A, Khaled W, Klotsche J, Tonn T, Dimmeler S, Zeiher AM, Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. JAMA 2013; 309: 1622-1631. doi: 10.1001/jama.2013.3527
23. Nasseri BA, Ebell W, Dandel M, Kukucka M, Gebker R, Doltra A, Knosalla C, Choi YH, Hetzer R, Stamm C, Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Eur Heart J 2014; 35: 1263-1274. doi: 10.1093/eurheartj/ehu007
24. Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HC Jr, Kormos R, Benetti F, Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005; 130: 1631-1638. doi: 10.1016/j.jtcvs.2005.07.056
25. Perin EC, Silva GV, Henry TD, A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011; 161: 1078-87.e3. doi: 10.1016/j.ahj.2011.01.028
26. Turan RG, Bozdag-Turan I, Ortak J, Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease. Stem Cells Dev 2011; 20: 1491-1501. doi: 10.1089/scd.2010.0373
27. Turan RG, Bozdag-T I, Ortak J, Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev 2011; 7: 646-656. doi: 10.1007/s12015-010-9220-8
28. Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J, Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008; 94: 1147-1153. doi: 10.1136/hrt.2007.137919
29. Mozid A, Yeo C, Arnous S, Ako E, Saunders N, Locca D, Brookman P, Archbold RA, Rothman M, Mills P, Agrawal S, Martin J, Mathur A, Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study. Regen Med 2014; 9: 269-278. doi: 10.2217/rme.14.3
30. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM, Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-1232. doi: 10.1056/NEJMoa051779
31. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E, Ingels M, Jacobs A, Geukens R, Dendale P, Vijgen J, Dilling D, Steels P, Mees U, Rummens JL, Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006 114 I101 I107. doi: 10.1161/CIRCULATIONAHA.105.000505
32. Pätilä T, Lehtinen M, Vento A, Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass. J Heart Lung Transplant 2014; 33: 567-574. doi: 10.1016/j.healun.2014.02.009
33. Perin EC, Silva GV, Zheng Y, Gahremanpour A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA, Moore WH, Herlihy JP, Willerson JT, Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J 2012; 163: 415-21., 421.e1. doi: 10.1016/j.ahj.2011.11.020
34. Zhao Q, Sun Y, Xia L, Chen A, Wang Z, Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008; 86: 1833-1840. doi: 10.1016/j.athoracsur.2008.08.068
35. Hu S, Liu S, Zheng Z, Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2011; 57: 2409-2415. doi: 10.1016/j.jacc.2011.01.037
36. Lu M, Liu S, Zheng Z, Yin G, Song L, Chen H, Chen X, Chen Q, Jiang S, Tian L, He Z, Hu S, Zhao S, A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction. Int J Cardiol 2013; 168: 2221-2227. doi: 10.1016/j.ijcard.2013.01.217
37. Duckers HJ, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys PW, Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 2011; 6: 805-812. doi: 10.4244/EIJV6I7A139
38. Vrtovec B, Sever M, Domanovic D, Lezaic L, Poglajen G, Cernelc P, Haddad F, Torre-Amione G, Long-term effects of stem cell transplantation in heart failure. Zdrav Vestn Supl 2012 II-373 II-383
39. Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P, Socan A, Schrepfer S, Torre-Amione G, Haddad F, Wu JC, Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res 2013; 112: 165-173. doi: 10.1161/CIRCRESAHA.112.276519
40. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group; Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011 343 d5928
41. Review Manager (RevMan) [computer program]. 2011
42. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA, The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117: 1189-1200. doi: 10.1161/CIRCULATIONAHA.107.734103
43. Brickwedel J, Gulbins H, Reichenspurner H, Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease. Interact Cardiovasc Thorac Surg 2014; 18: 61-66. doi: 10.1093/icvts/ivt434
44. Povsic TJ, O'Connor CM, Henry T, Taussig A, Kereiakes DJ, Fortuin FD, Niederman A, Schatz R, Spencer R IV, Owens D, Banks M, Joseph D, Roberts R, Alexander JH, Sherman W, A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am Heart J 2011; 162: 654-662.e1. doi: 10.1016/j.ahj.2011.07.020
45. Weber M, Hamm C, Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92: 843-849. doi: 10.1136/hrt.2005.071233
46. Higgins JP, Thompson SG, Deeks JJ, Altman DG, Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. doi: 10.1136/bmj.327.7414.557
47. Higgins JP, Thompson SG, Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558. doi: 10.1002/sim.1186
48. Bocchi EA, Bacal F, Guimarães G, Mendroni A, Mocelin A, Filho AE, Dores da Cruz Fd, Resende MC, Chamone D, Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure. Int J Cardiol 2010; 138: 94-97. doi: 10.1016/j.ijcard.2008.06.002
49. Bolli R, Chugh AR, D'Amario D, Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-1857. doi: 10.1016/S0140-6736(11)61590-0
50. Chen S, Liu Z, Tian N, Zhang J, Yei F, Duan B, Zhu Z, Lin S, Kwan TW, Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 2006; 18: 552-556.
51. Dib N, Dinsmore J, Lababidi Z, White B, Moravec S, Campbell A, Rosenbaum A, Seyedmadani K, Jaber WA, Rizenhour CS, Diethrich E, One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2009; 2: 9-16. doi: 10.1016/j.jcin.2008.11.003
52. Honold J, Fischer-Rasokat U, Lehmann R, Leistner DM, Seeger FH, Schachinger V, Martin H, Dimmeler S, Zeiher AM, Assmus B, G-CSF stimulation and coronary reinfusion of mobilized circulating mononuclear proangiogenic cells in patients with chronic ischemic heart disease:five-year results of the TOPCARE-G-CSF trial. Cell Transplant 2012; 21: 2325-2337. doi: 10.3727/096368912X654957
53. Maureira P, Tran N, Djaballah W, Angioï M, Bensoussan D, Didot N, Fay R, Sadoul N, Villemot JP, Marie PY, Residual viability is a predictor of the perfusion enhancement obtained with the cell therapy of chronic myocardial infarction: a pilot multimodal imaging study. Clin Nucl Med 2012; 37: 738-742. doi: 10.1097/RLU.0b013e318251e38a
54. Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, Kumar L, Reddy KS, Venugopal P, AIIMS Cardiovascular Stem Cell Study Group Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006; 48: 2350-2351. doi: 10.1016/j.jacc.2006.07.057
55. Seth S, Bhargava B, Narang R, Ray R, Mohanty S, Gulati G, Kumar L, Airan B, Venugopal P, AIIMS Stem Cell Study Group The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study. J Am Coll Cardiol 2010; 55: 1643-1644. doi: 10.1016/j.jacc.2009.11.070
56. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012 126 S54 S64. doi: 10.1161/CIRCULATIONAHA.112.092627
57. Nowbar AN, Mielewczik M, Karavassilis M, Dehbi HM, Shun-Shin MJ, Jones S, Howard JP, Cole GD, Francis DP, DAMASCENE writing group Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 2014 348 g2688
58. Strauer BE, Yousef M, Schannwell CM, The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 2010; 12: 721-729. doi: 10.1093/eurjhf/hfq095
59. Strauer BE, Brehm M, Zeus T, Bartsch T, Schannwell C, Antke C, Sorg RV, Kögler G, Wernet P, Müller HW, Köstering M, Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005; 46: 1651-1658. doi: 10.1016/j.jacc.2005.01.069
60. Sadat K, Ather S, Aljaroudi W, Heo J, Iskandrian AE, Hage FG, The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. J Nucl Cardiol 2014; 21: 351-367. doi: 10.1007/s12350-013-9846-4
61. Jiang M, He B, Zhang Q, Ge H, Zang MH, Han ZH, Liu JP, Li JH, Zhang Q, Li HB, Jin Y, He Q, Gong XR, Yin XY, Randomized controlled trials on the therapeutic effects of adult progenitor cells for myocardial infarction: meta-analysis. Expert Opin Biol Ther 2010; 10: 667-680. doi: 10.1517/14712591003716437
62. Donndorf P, Kundt G, Kaminski A, Yerebakan C, Liebold A, Steinhoff G, Glass A, Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg 2011; 142: 911-920. doi: 10.1016/j.jtcvs.2010.12.013
63. Zhao Q, Ye X, Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and meta-analysis. Expert Opin Biol Ther 2011; 11: 1569-1579. doi: 10.1517/14712598.2011.616491
64. Xu R, Ding S, Zhao Y, Pu J, He B, Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: A systematic review and meta-analysis. Can J Cardiol 2014. S0828-282X(14)00044-0
65. Janssens S, Dubois C, Bogaert J, Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-121. doi: 10.1016/S0140-6736(05)67861-0
66. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012; 379: 895-904. doi: 10.1016/S0140-6736(12)60195-0
67. Perin E, Transendocardial injection of autologous mononuclear bone marrow cells in end-stage ischemic heart failure patients: one-year follow-up. Int J Cardiol 2004; 95 (Suppl 1) S45-S46.
68. Bello D, Einhorn A, Kaushal R, Kenchaiah S, Raney A, Fieno D, Narula J, Goldberger J, Shivkumar K, Subacius H, Kadish A, Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging 2011; 29: 50-56. doi: 10.1016/j.mri.2010.03.031
69. Menasche P, How close are we to using stem cells in routine cardiac therapy? Can J Cardiol 2014. S0828-282X(14)00232-3
70. Cheng K, Ibrahim A, Hensley MT, Shen D, Sun B, Middleton R, Liu W, Smith RR, Marbán E, Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction. J Am Heart Assoc 2014 3 e001260. doi: 10.1161/JAHA.114.001260